Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
3,475 results in PubMed
Peer-reviewed biomedical literature from the US National Library of Medicine, most relevant first. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis.
Conceição M, Shteinberg M, Goeminne P, et al. · Eur Respir Rev · 2024Meta-Analysis, Systematic Review
- The effect of respiratory muscle training on children and adolescents with cystic fibrosis: a systematic review and meta-analysis.
Cai W, Li M, Xu Y, et al. · BMC Pediatr · 2024Meta-Analysis, Systematic Review
- Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double-blind, placebo-controlled phase 1/2 clinical study.
Rowe SM, Zuckerman JB, Dorgan D, et al. · J Cyst Fibros · 2023Randomized Controlled Trial, Clinical Trial, Phase I
- Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial.
Weiner I, Kahan-Hanum M, Buchstab N, et al. · Nat Commun · 2025Randomized Controlled Trial, Clinical Trial, Phase I
- Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis.
Warnock L, Gates A · Cochrane Database Syst Rev · 2023Systematic Review, Meta-Analysis
- Interventions for preventing and managing advanced liver disease in cystic fibrosis.
Palaniappan SK, Than NN, Thein AW, et al. · Cochrane Database Syst Rev · 2020Meta-Analysis, Research Support, Non-U.S. Gov't
- Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.
Mall MA, Brugha R, Gartner S, et al. · Am J Respir Crit Care Med · 2022Randomized Controlled Trial, Clinical Trial, Phase III
- The clinical effectiveness of elexacaftor/tezacaftor/ivacaftor (ETI) for people with CF without a F508del variant: A systematic review and meta-analysis.
Lupas D, Chou FY, Hakani MAA, et al. · J Cyst Fibros · 2024Systematic Review, Meta-Analysis
- Sleep disorders in cystic fibrosis: A systematic review and meta-analysis.
Reiter J, Gileles-Hillel A, Cohen-Cymberknoh M, et al. · Sleep Med Rev · 2020Meta-Analysis, Research Support, N.I.H., Extramural
- Sweat conductivity diagnostic accuracy for cystic fibrosis: a systematic review and meta-analysis.
Zhang L, Nomiyama S, Bedran RM, et al. · Arch Dis Child · 2023Meta-Analysis, Systematic Review
- Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: a systematic review and meta-analysis.
Lord L, McKernon D, Grzeskowiak L, et al. · Soc Psychiatry Psychiatr Epidemiol · 2023Meta-Analysis, Systematic Review
- Inhaled corticosteroids for cystic fibrosis.
Balfour-Lynn IM, Welch K · Cochrane Database Syst Rev · 2016Meta-Analysis, Research Support, Non-U.S. Gov't
- Inhaled corticosteroids for cystic fibrosis.
Balfour-Lynn IM, Welch K · Cochrane Database Syst Rev · 2014Meta-Analysis, Systematic Review
- Dornase alfa for cystic fibrosis.
Yang C, Montgomery M · Cochrane Database Syst Rev · 2021Meta-Analysis, Research Support, Non-U.S. Gov't
- Clinical outcomes after liver transplant in people with cystic fibrosis: A systematic review and meta-analysis.
Albaiz FA, Semenchuk J, Ma X, et al. · J Cyst Fibros · 2024Systematic Review, Meta-Analysis
- Peak Oxygen Uptake and Mortality in Cystic Fibrosis: Systematic Review and Meta-Analysis.
Vendrusculo FM, Heinzmann-Filho JP, da Silva JS, et al. · Respir Care · 2019Meta-Analysis, Systematic Review
- Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location.
Gold LS, Hansen RN, Heltshe SL, et al. · J Cyst Fibros · 2024Randomized Controlled Trial, Research Support, N.I.H., Extramural
- Self-management education for cystic fibrosis.
Savage E, Beirne PV, Ni Chroinin M, et al. · Cochrane Database Syst Rev · 2014Meta-Analysis, Research Support, Non-U.S. Gov't
- Dornase alfa for cystic fibrosis.
Yang C, Chilvers M, Montgomery M, et al. · Cochrane Database Syst Rev · 2016Meta-Analysis, Research Support, Non-U.S. Gov't
- Vitamin D supplementation in patients with cystic fibrosis: A systematic review and meta-analysis.
Juhász MF, Varannai O, Németh D, et al. · J Cyst Fibros · 2021Meta-Analysis, Research Support, Non-U.S. Gov't
- The Status of Carbapenem Resistance in Cystic Fibrosis: A Systematic Review and Meta-Analysis.
Saadh MJ, Lohrasbi A, Ghasemian E, et al. · Yale J Biol Med · 2022Meta-Analysis, Systematic Review
- Vitamin D deficiency in patients with cystic fibrosis: a systematic review and meta-analysis.
Farahbakhsh N, Fatahi S, Shirvani A, et al. · J Health Popul Nutr · 2024Meta-Analysis, Systematic Review
- Antibiotic treatment for non-tuberculous mycobacteria lung infection in people with cystic fibrosis.
Jahnke N, Waters V, Ratjen F, et al. · Cochrane Database Syst Rev · 2025Meta-Analysis, Systematic Review
- Cisapride in cystic fibrosis.
Prinsen JE, Thomas M · Lancet · 1985Case Reports, Clinical Trial
- Inhaled mannitol for cystic fibrosis.
Nevitt SJ, Thornton J, Murray CS, et al. · Cochrane Database Syst Rev · 2020Meta-Analysis, Research Support, Non-U.S. Gov't
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.